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ConfBackground: Dermoscopy improves the recognition of melanoma and Spitz nevus but occasionally
melanoma may exhibit a symmetric pattern mimicking Spitz nevus.Objective: We sought to investigate the likelihood of finding melanoma when excising a symmetric
Spitzoid-looking lesion in patients aged 12 years or older.Methods: This study included patients aged 12 years or older with symmetric, Spitzoid-looking lesions that
were diagnosed histopathologically as Spitz nevus or melanoma. Demographic, clinical, and dermoscopic
variables were included in the analysis. We used x2 for nonparametric comparisons. Crude odds ratios and
95% confidence intervals were calculated by univariate logistic regression.Results: Of 384 included lesions, 333 (86.7%) were histopathologically diagnosed as Spitz nevus and 51
(13.3%) as melanoma. The risk of melanoma significantly increased with increasing age, being 50% or
higher after the age of 50 years.Limitations: Limitations are retrospective design, exclusion of patients younger than 12 years, lack of
detailed histopathologic data, and limited sample size.Conclusion: Our results confirm the observation that melanoma may be dermoscopically indistin-
guishable from Spitz nevi, strongly suggesting that the only safe strategy not to miss melanoma is to
excise all Spitzoid-looking lesions in patients aged 12 years or older. ( J Am Acad Dermatol
2015;72:47-53.)
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fter the initial description of Spitz nevus, the
clarification of its biologic nature has been a
source of controversy among clinicians and
pathologists for several decades.1,2 Today, Spitzoid
tumors are considered a heterogeneous family of
lesions that share similar clinical and histopathologic
features, but differ significantly concerning their
biologic behavior.3-5 On the 2 opposite edges, Spitz
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and involution, whereas Spitzoid melanoma carries a
prognosis not different from melanoma lacking
Spitzoid features.6-9
Dermoscopy significantly improved the recogni-
tion of Spitz nevi, because they have been shown
to exhibit a characteristic pattern of morphologic
structures.10-12 In detail, pigmented Spitz nevusAccepted for publication September 17, 2014.
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starburst pattern, which consists of a central area of
homogenous blue to black pigmentation and pe-
ripheral, radially, and symmetrically distributed
dark-brown to black streaks or pseudopods.
Globular, homogenous, reticular, and multicompo-
nent patterns can also be found in pigmented SpitzCAPSULE SUMMARY
d Dermoscopy improves the recognition of
melanoma and Spitz nevus but
occasionally melanoma may exhibit a
symmetric pattern mimicking Spitz
nevus.
d The likelihood of finding melanoma
when excising a symmetric Spitzoid-
looking tumor in patients aged 12 years
or older is 13.3%. The probability
increases to 50% or higher after the age
of 50 years.
d Our results highlight that the only safe
strategy not to miss melanoma is to
excise all Spitzoid-looking lesions in
patients aged 12 years or older.nevi, but they are less com-
mon and less specific.12,13
Dermoscopy of nonpig-
mented Spitz nevus usually
reveals symmetrically distrib-
uted dotted vessels combined
with the so-called ‘‘inverse
network’’ or ‘‘reticular depig-
mentation.’’14-16 The latter
criterion has been assessed
as highly specific for the
diagnosis of pigmented and
nonpigmented Spitzoid le-
sions and corresponds, in
the analytic terminology, to
white crossing lines in be-
tween the vascular structures
or the pigmented globules.16
From amorphologic point
of view, a Spitzoid pattern by
definition presupposes a
symmetric arrangement of colors and structures. In
contrast, asymmetrically distributed peripheral
streaks, pseudopods, or globules are considered
melanoma criteria, which are usually combined to
each other forming the so-called ‘‘multicomponent
pattern.’’17-19 However, the rule of symmetry has its
limitations. Previous studies have shown that about
20% of Spitz nevi may exhibit an asymmetric and/or
multicomponent pattern and, on the opposite, a
certain proportion of melanomas may exhibit a
symmetric Spitzoid pattern.11,12 The aim of this study
was to investigate the likelihood of finding mela-
noma when excising a symmetric Spitzoid-looking
lesion in patients aged 12 years or older.
METHODS
This was a retrospective study conducted at 2
specialized units for skin cancer diagnosis and man-
agement in Modena and Reggio Emilia, Italy. The
databases of our centers were screened for eligible
patients with excised Spitzoid-looking lesions.
Because themanagement of Spitzoid-looking lesions
varies significantly among different centers, a clari-
fication of our standard procedure is required:
routinely in our units, typical Spitzoid-looking le-
sions in patients younger than 12 years of age enter
regular follow-up until stabilization. Instead, therecognition of a Spitzoid-looking lesion in patients
aged 12 years or older warrants excision, even if the
dermoscopic morphology of the lesion is completely
symmetric.
This study included only lesions fulfilling all of the
3 following criteria: (1) a clinical-dermoscopic diag-
nosis of Spitz nevus, (ie, typified either by acompletely symmetric star-
burst or globular pattern, or
by symmetrically distributed
dotted vessels, combined
or not with an inverse
network); (2) patients aged
12 years or oldereas
mentioned above, Spitzoid-
looking lesions in patients of
this age group are routinely
excised in our centers; and
(3) a histopathologic diag-
nosis of Spitz nevus or
melanoma. Based on the
aforementioned inclusion
criteria, Spitzoid lesions der-
moscopically exhibiting an
asymmetric distribution of
colors or structures and
lesions histopathologically
diagnosed as atypical Spitztumor were not included in the current study.
Patients’ age and sex, along with the anatomic site
of the tumor were recorded and 2 independent
investigators evaluated the clinical and dermoscopic
images of the included lesions. A third investigator
was involved in case of disagreement. The clinical
images were used to classify the tumors as flat/
slightly elevated or nodular, and the dermoscopic
ones to assess the presence of pigmentation. Lesions
dermoscopically displaying pigmentation on less
than 10% of their surface were classified as
nonpigmented.
Statistical analysis
Outcome dichotomous variable was set to
definite histopathologic diagnosis of melanoma or
Spitz nevus. Demographic, clinical, and dermo-
scopic variables were included in the analysis.
Colinearity was assessed via a correlation matrix,
using Spearman Rho correlation coefficient.
Nonparametric Mann-Whitney U test was used to
compare means. Pearson x2 was used for nonpara-
metric cross-tabulation comparisons. Relative risks
were calculated for dichotomous variables. Crude
odds ratios and corresponding 95% confidence
intervals were calculated by univariate logistic
regression.
Table I. Clinical and dermoscopic characteristics: cross-tabulation by histologic diagnosis from 384 patients
with excised Spitzoid-looking lesions
Nevus (n = 333)
N, (%)
Melanoma (n = 51)
N, (%) P value
Age, y (mean 6 SD) 32.87 6 10.91 44.78 6 15.36 \.001*
Anatomic site
Head/neck 9 (2.7%) 2 (3.9%) .829y
Thorax 21 (6.3%) 2 (3.9%)
Abdomen 21 (6.3%) 3 (5.9%)
Back 63 (18.9%) 7 (13.7%)
Upper extremities 54 (16.2%) 10 (19.6%)
Lower extremities 143 (42.9%) 23 (45.1%)
Acral 13 (3.9%) 1 (2.0%)
Buttock 9 (2.7%) 3 (5.9%)
Clinical characteristics
Nodular tumor 19 (5.7%) 9 (17.6%) .006y
Dermoscopic characteristics
Presence of pigment 287 (86.2%) 44 (86.3%) .986y
Pattern
Starburst 204 (61.3%) 36 (70.6%) .430y
Globular 82 (24.6%) 10 (19.6%)
Dotted vessels 47 (14.1%) 5 (9.8%)
Inverse network 52 (15.6%) 7 (13.7%) .727y
*Mann-Whitney U.
yPearson x2.
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classified as failures. Assuming 20% failures among
study lesions and 5% failures among remaining
lesions, we would be able to reject the null hypoth-
esis that the failure rates for each group of lesions are
equal with probability (power) of 0.866. A Fisher
exact x2 statistic was used to evaluate this null
hypothesis.
The type I error probability associated with all
tests in this study was set to 0.05. An alpha less than
0.10 was considered to signify a trend. All statistical
calculations were made with software (SPSS 17.0,
IBM Corp, Armonk, NY).
RESULTS
Of 384 included patients, 131 were male and 253
female. Mean age was 33.87 6 12.78 years for male
patients and 34.75 6 12.00 for female patients,
ranging from 12 to 85 years (Mann-Whitney U test,
P = .399). In 51 patients (13.3%) the histopathologic
diagnosis was melanoma and in 333 (86.7%) it was
Spitz nevus. Of 51 melanomas, 19 were in situ and
33 were invasive with a mean Breslow thickness of
0.86 mm.
The most frequent body site of involvement was
the lower extremities (166/384 lesions, 43.3%),
followed by the back (70/384, 18.2%) and upper
extremities (64/384, 16.7%). Analytic results of the
anatomic site of the tumor development are pre-
sented in Table I. No significant difference was foundbetween nevi and melanoma concerning the tumor
localization.
Both groups (nevi and melanoma) were charac-
terized by a female predominance and the gender
was not associated with a specific histopathologic
diagnosis (rho = 0.26, P = .613).
Based on the evaluation of the clinical images, 356
of 384 tumors were flat or slightly elevated (92.7%)
and 28 were nodular (7.3%). Nine of 51 melanomas
(17.6%) and 19 of 333 nevi (5.7%) were nodular
(Pearson x2, P = .002). The possibility of a nodular
lesion being a melanoma was 32.1%, significantly
higher compared with flat lesions (11.8%), posing a
3-fold higher risk of melanoma for nodular tumors
(odds ratio 3.541, 95% confidence interval 1.505-
8.335, P = .004).
The analysis of the dermoscopic images revealed
that 331 lesions were pigmented (86.2%), whereas 53
tumors (13.8%) were not pigmented (Figs 1-3). The
pigmentation status did not differ between Spitz
nevus and melanoma, with 287 of 333 nevi (86.2%)
and 44 of 51 melanomas (86.3%) being pigmented.
Acral Spitzoid-looking tumors were more frequently
nonpigmented, comparing with all other anatomic
sites (Pearson x2, P = .036). No other correlation was
observed between the pigmentation status and the
anatomic site of the lesion.
Based on the dermoscopic analysis, the starburst
was the most common pattern both for nevi and
melanomas, followed by globular and the pattern of
Fig 2. Spitz nevus and melanoma. Nonpigmented Spitz nevus (A) typically exhibits a
symmetric pattern of dotted vessels in dermoscopy. Spitzoid amelanotic melanoma (B) can
perfectly mimic this pattern.
Fig 1. Spitz nevus and melanoma. The stereotypical starburst pattern of a Spitz nevus (A),
consisting of a structureless center and peripheral streaks, symmetrically and radially
distributed. B, A melanoma exhibiting starburst pattern.
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inverse network was present in 52 of 333 nevi
(15.6%) and in 7 of 51 melanomas (13.7%). No
difference was observed between nevi and mela-
nomas concerning the global dermoscopic pattern
or the presence of inverse network. The presence ofinverse network was significantly associated with a
pattern of dotted vessels or a globular pattern,
compared with the starburst pattern.
As analytically shown in Table II, the odds for
melanoma gradually increase with age, as demon-
strated by the increasing odds ratios (some of them
Fig 3. Spitz nevus and melanoma. A partially pigmented Spitz nevus (A) and a melanoma (B),
both dermoscopically typified by a pattern of globules and an inverse network.
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of 51 melanomas (2%) occurred in the age category
of 12 to 20 years. This was a 0.78 mmethick
melanoma developing on the lower extremity of a
20-year-old male patient. Using age 12 to 20 years as
a reference category, patients aged 21 to 30 years had
a 4-fold higher risk for melanoma (P = .181, not
significant), which increased to a 6-fold higher risk
for ages 31 to 40 years (P = .096, trend) and 41 and 50
years (P = .095, trend). In patients older than 50
years, the risk of melanoma increased to a 20-fold
higher risk in those aged 51 to 60 years (P = .006) and
a 132-fold higher risk from ages 61 to 70 years (P\
.001). Finally, only 2 tumors occurred in patients
older than 70 years, both diagnosed as melanoma.
DISCUSSION
According to our results, the likelihood of finding
melanoma when excising a completely symmetric
Spitzoid-looking lesion in patients aged 12 years or
older is 13.3%, and this risk significantly increases
with increasing age, becoming 50% or higher after
the age of 50 years.
The epidemiologic characteristics of our patients
are in agreement with pre-existing studies reporting
a female predominance of Spitz nevi.7,20,21 Notably,
neither the gender nor the tumor localization was
associated with a specific histopathologic diagnosis.
The morphologic similarity between Spitz nevus
and melanoma poses significant difficulties in the
clinical management of Spitzoid-looking tumors.22This problem has not been sufficiently solved by
dermoscopy, because, as confirmed by our findings,
melanoma might display a completely symmetric
dermoscopic pattern, perfectly mimicking a Spitz
nevus.
To overcome this problem, some clinicians are
prone to excise all Spitzoid-looking lesions, irre-
spectively of the patient age.9,22-24 This approach
eliminates the risk of missing melanoma, but results
also in numerous unnecessary excisions of nevi,
especially in children. Another approach, based on
the evidence that melanoma is extremely rare before
puberty,25 is to monitor typical Spitz nevi in child-
hood until stabilization,26,27 while excising Spitzoid-
looking lesions after puberty, even if completely
symmetric.28,29 Although not based on appropriately
designed studies, the most widely accepted age cut-
off is 12 years.9
In contrast, the results of the current study
highlight that the overall scenario changes
completely in patients aged 12 years or older, with
13.3% of Spitzoid-looking lesions being melanomas.
Furthermore, our findings suggest the age of 50 years
as a threshold, after which the risk of melanoma is
equal or higher than the possibility of a nevus,
whereas after 70 years of age, a Spitzoid dermo-
scopic pattern is absolutely predictive of melanoma.
More than 1 of 3 Spitzoid-looking melanomas
included in this study were in situ (37.3%), and the
mean Breslow thickness of the invasive tumors was
less than 1 mm (0.86 mm). This result can probably
Table II. Age group as a predictor of the
histopathologic diagnosis of melanoma




21-30 .181 4.151 0.516 33.408
31-40 .096 5.778 0.733 45.547
41-50 .095 6.000 0.734 49.041
51-60 .006* 20.533* 2.331* 180.864*
61-70 .000* 132.000* 12.290* 1417.776*
Univariate logistic regression with categorical variable coding.
CI, Confidence interval; OR, odds ratio.
*Statistically significant.
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advanced Spitzoid melanomas often develop der-
moscopic characteristics that deviate the completely
symmetric Spitzoid pattern, and were, effectively,
excluded.
Notably, the benign-to-malignant ratio in our
study was 6.5/1, highlighting that the procedure to
excise all Spitzoid-looking tumors in patients aged 12
years or older results in an acceptable number of
unnecessary interventions. Some investigators have
proposed a different approach for nodular Spitz
nevi, comparing with the classic flat, pigmented
Reed nevi. According to the latter approach, nodular
lesions are considered at higher risk for melanoma
and should be excised irrespective of the patient age,
whereas flat pigmented nevi could be monitored.30
Although our study confirmed that nodular lesions
are associated with a higher possibility of melanoma
(32.1%), the risk of flat lesions remains considerable
(11.8%). No other clinical or dermoscopic criterion
was shown to predict the diagnosis of melanoma
among Spitzoid-looking lesions.
Our study has some limitations. First, the retro-
spective design is subject to recall and observation
bias. To address this problem, the evaluation was
performed by 2 independent investigators, blinded
to the histopathologic diagnosis, and a third inves-
tigator was involved in case of disagreement.
Second, our study did not include patients younger
than 12 years of age and, consequently, no conclu-
sions can be drawn concerning the management of
Spitzoid-looking lesions in this age group. Third, the
assessment of the tumor’s palpability based on a
clinical image is subject to observation bias. To
minimize this problem, the evaluation was per-
formed by 2 independent investigators and a third
investigator was involved in the event of disagree-
ment. However, we still cannot rule out misclassifi-
cations between flat and nodular tumors. Fourth,
because we did not evaluate the individualhistopathologic features of each tumor, no conclu-
sions can be extracted concerning the histopatho-
logic correlation of dermoscopic criteria. This would
be an interesting topic for a study with an appro-
priate design. Fifth, although histopathologic exam-
ination is considered the gold standard for diagnosis
of melanocytic tumors, the differentiation between
Spitz nevus and melanoma might be very difficult
even histopathologically in some cases. To minimize
this bias, we included only cases with a definite
histopathologic diagnosis. However, we still cannot
rule out that some tumors were misdiagnosed.
Finally, the small number of cases in our study did
not allow modeling a classification and regression
tree, which would probably require a multicenter
study with a higher number of patients.
In conclusion, our results confirm the observation
that melanoma may be dermoscopically indistin-
guishable from Spitz nevi, strongly suggesting that
the only safe strategy not to miss melanoma is to
excise all Spitzoid-looking lesions in patients aged 12
years or older.
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